Nunoda Kousuke | First Department Of Internal Medicine Tokyo Medical University
スポンサーリンク
概要
関連著者
-
TAUCHI Tetsuzo
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
OHYASHIKI Kazuma
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
OKABE Seiichi
First Department of Internal Medicine, Tokyo Medical University
-
AKAHANE Daigo
First Department of Internal Medicine, Tokyo Medical University
-
NUNODA Kousuke
First Department of Internal Medicine, Tokyo Medical University
-
Ohyashiki K
Tokyo Medical Univ. Tokyo Jpn
-
Ohyashiki Kazuma
First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University
-
Ohyashiki Kazuma
First Department Of Internal Medicine (hematology Division) Tokyo Medical University
-
Ohyashiki Kazuma
First Deparmtne Of Internal Medicine Tokyo Medical University
-
Tsunoda Tatsuhiko
Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res
-
Tauchi T
First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University
-
Okabe Seiichi
First Department Of Internal Medicine Tokyo Medical University
-
Akahane Daigo
First Department Of Internal Medicine Tokyo Medical University
-
Nunoda Kousuke
First Department Of Internal Medicine Tokyo Medical University
-
Tauchi Tetsuzo
First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University
-
ISHII Yuko
First Department of Internal Medicine, Tokyo Medical University
-
HONDA Seiko
First Department of Internal Medicine, Tokyo Medical University
-
TAKAKU Tomoiku
First Department of Internal Medicine, Tokyo Medical University
-
Honda Seiko
First Department Of Internal Medicine Tokyo Medical University
-
Takaku Tomoiku
First Department Of Internal Medicine Tokyo Medical University
-
Tauchi Tetsuzo
Department Of Medicine (hematology/oncology) Indiana University School Of Medicine Walther Oncology
-
Ishii Yuko
First Department Of Internal Medicine Tokyo Medical University
著作論文
- Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL : In vitro and in vivo studies
- Sustained Complete Cytogenetic Remission in a Patient with Chronic Myeloid Leukemia after Discontinuation of Imatinib Mesylate Therapy